?

Keeney Adam

Head of Corporate Development
Biogen Inc.
US, Cambridge [HQ]
CIK 1973607

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
938
Price per Share :
$140.55
Equivalence :
$131,835.90

Transaction History

  • M
    Form 4
    938 Shares After Transaction
    Value : $n/a
    $0.0
    05/01/24
  • Footnotes:
    No footnote found.
  • F
    Form 4
    662 Shares After Transaction
    Value : $143,078.06
    $59,651.88
    05/01/24